Follow
Michael Duhig
Michael Duhig
Centre for Clinical Trials in Rare Neurodevelopemental Disorers, Children's Health Queensland
Verified email at health.qld.gov.au - Homepage
Title
Cited by
Cited by
Year
The prevalence and correlates of childhood trauma in patients with early psychosis
M Duhig, S Patterson, M Connell, S Foley, C Capra, F Dark, A Gordon, ...
Australian & New Zealand Journal of Psychiatry 49 (7), 651-659, 2015
1222015
Modifiable risk factors for schizophrenia and autism—shared risk factors impacting on brain development
J Hamlyn, M Duhig, J McGrath, J Scott
Neurobiology of disease 53, 3-9, 2013
712013
A pilot study of the effects of an Australian centre-based early intervention program for children with autism
J Paynter, J Scott, W Beamish, M Duhig, H Heussler
The Open Pediatric Medicine Journal 6 (1), 2012
372012
Implementing music therapy on an adolescent inpatient unit: A mixed-methods evaluation of acceptability, experience of participation and perceived impact
S Patterson, M Duhig, C Darbyshire, R Counsel, N Higgins, I Williams
Australasian Psychiatry 23 (5), 556-560, 2015
312015
The association between maltreatment in childhood and pre-pregnancy obesity in women attending an antenatal clinic in Australia
K Hollingsworth, L Callaway, M Duhig, S Matheson, J Scott
PLoS One 7 (12), e51868, 2012
302012
Understanding readmission to psychiatric hospital in Australia from the service users’ perspective: a qualitative study
M Duhig, I Gunasekara, S Patterson
Health & social care in the community 25 (1), 75-82, 2017
242017
Successful recruitment to a study of first-episode psychosis by clinicians: a qualitative account of outcomes and influences on process
S Patterson, M Duhig, M Connell, J Scott
Journal of Mental Health 23 (5), 225-230, 2014
132014
National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story
S Hollingworth, M Duhig, W Hall, J Scott
Australasian Psychiatry 21 (5), 442-445, 2013
122013
Environmental contributions to autism: explaining the rise in incidence of autistic spectrum disorders
J Scott, M Duhig, J Hamlyn, R Norman
Journal of Environmental Immunology and Toxicology 1 (2), 75-79, 2014
92014
Efficacy of risperidone in children with disruptive behavioural disorders
MJ Duhig, S Saha, JG Scott
Journal of Paediatrics and Child Health 49 (1), 19-26, 2013
72013
& Scott, J.(2015). The prevalence and correlates of childhood trauma in patients with early psychosis
M Duhig, S Patterson, M Connell, S Foley, C Capra, F Dark
Australian and New Zealand Journal of Psychiatry 49 (7), 0
5
Longer-term Tolerability and Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Autism Spectrum Disorder: An Open-label Phase 2 Study (BRIGHT [ZYN2 …
JM Palumbo, H Heussler, MJ Duhig, T Hurst, C O’Neill, T Sebree
Pediatrics 149 (1 Meeting Abstracts February 2022), 264-264, 2022
2022
Longer-Term Tolerability and Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Autism Spectrum Disorder: an Open-Label Phase 2 Study (BRIGHT [ZYN2 …
H Heussler, M Duhig, T Hurst, C O'Neill, D Gutterman, J Palumbo
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS 43 (2), E142-E142, 2022
2022
LONGER-TERM TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY (BRIGHT [ZYN2 …
J Palumbo, H Heussler, M Duhig, T Hurst, C O'Neill, T Sebree
Journal of the American Academy of Child & Adolescent Psychiatry 60 (10), S258, 2021
2021
[Bright (ZYN2-CL-030)] Tolerability and Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents With Autism Spectrum Disorder: An Open-Label Phase 2 Study
DM Helen Heussler FRACP, M Duhig, T Hurst, C O'Neill, D Gutterman, ...
2020 Virtual Meeting, 2020
2020
[BRIGHT (ZYN2-CL-030)] TOLERABILITY AND EFFICACY OF ZYN002 CANNABIDIOL TRANSDERMAL GEL IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER: AN OPEN-LABEL PHASE 2 STUDY
H Heussler, M Duhig, T Hurst, C O'Neill, D Gutterman, JM Palumbo
Journal of the American Academy of Child & Adolescent Psychiatry 59 (10 …, 2020
2020
Phase 2 BRIGHT (An open-label tolerability and efficacy study of ZYN002 administered as a transdermal gel to children and adolescents with autism spectrum disorder): Baseline …
H Heussler, M Duhig, T Hurst, C O'Neill, W Agnese, JM Palumbo
NEUROTHERAPEUTICS 17 (3), 1321-1322, 2020
2020
Longer Term Tolerability and Efficacy of ZYN002 Cannabidiol Transdermal Gel in Children and Adolescents with Autism Spectrum Disorder (ASD): An Open-Label Phase 2 Study (BRIGHT …
H Heussler, M Duhig, T Hurst, C O’Neill, D Gutterman, JM Palumbo, ...
Adolescent Psychiatry (AACAP) 12, 24, 2020
2020
THE PREVALENCE AND CORRELATES OF CHILDHOOD TRAUMA IN PATIENTS WITH EARLY PSYCHOSIS
J Scott, M Duhig, L Hides
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY 49, 91-92, 2015
2015
Phase 2 BRIGHT (an Exploratory Open-Label Tolerability and Efficacy Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With Autism Spectrum Disorder …
H Heussler, M Duhig, T Hurst, C O’Neill, W Agnese, J Palumbo
The system can't perform the operation now. Try again later.
Articles 1–20